Reclaim Your Life With Expert Opioid Addiction Recovery

Prescription painkillers and illicit opioids rewire your brain and cause severe physical dependence. The fear of painful withdrawal keeps many trapped in the cycle of addiction. We provide a safe and comfortable clinical environment to manage your symptoms. Let our medical team guide you to a healthier and substance-free life.

Call (302) 555-1234

Confidential. Free assessment. Most insurance accepted.

Reclaim Your Life With Expert Opioid Addiction Recovery

Prescription painkillers and illicit opioids rewire your brain and cause severe physical dependence. The fear of painful withdrawal keeps many trapped in the cycle of addiction. We provide a safe and comfortable clinical environment to manage your symptoms. Let our medical team guide you to a healthier and substance-free life.

Call (302) 555-1234
  • Available 24/7
  • HIPAA Compliant
  • No Obligation

Confidential. Free assessment. Most insurance accepted.

15+
5000+
92%
24/7

Evidence-Based

Clinical Protocols
NIDA-aligned treatment approaches

Dual Diagnosis

Expertise
Integrated mental health & addiction care

Individualized

Treatment Planning
Tailored to each clinical profile

Nationwide

Care Network
Facilities across the United States

Clinical Overview Of Opioid Use Disorder (OUD)

Opioid use disorder is a chronic medical condition defined by the DSM-5 as a problematic pattern of opioid use causing significant impairment or distress. According to the Substance Abuse and Mental Health Services Administration (SAMHSA), approximately 2.7 million people in the United States meet criteria for opioid use disorder. Effective, evidence-based treatment is available.

Statistics sourced from SAMHSA and CDC.

Emergency Awareness Information

Recognizing and Responding to Opioid Overdose

If an overdose is suspected: Call 911 immediately.

Do not leave the person alone. Stay on the line with emergency services until help arrives.

Opioid overdose occurs when opioids suppress the central nervous system to a degree that compromises respiratory function. This constitutes a medical emergency. The following are clinically recognized warning signs. This information is provided for public health awareness – not as a substitute for emergency medical response.

Respiratory Depression

Extremely slow (fewer than one breath every 5 seconds), shallow, or completely stopped breathing – the primary mechanism of opioid overdose death.

Unresponsiveness

The person cannot be woken or is unable to respond to voice or touch. They may appear deeply asleep or unconscious.

Cyanosis

A blue or grayish discoloration of the lips, fingernails, or skin – indicating dangerously low oxygen levels in the blood.

Altered Consciousness

Extreme confusion, stupor, or a state between consciousness and unconsciousness.

Abnormal Sounds

Gurgling, choking, or ‘death rattle’ sounds – indicating a compromised airway.

Limpness

Complete muscle relaxation and limpness of the limbs.
Recognizing the Signs

Signs of Meth Addiction

Recognizing the signs of methamphetamine use disorder can help individuals and their loved ones seek timely, appropriate support.

Behavioral Signs


  • Escalating opioid use beyond prescribed amounts
  • Seeking multiple prescriptions from different providers
  • Withdrawal from social activities and relationships
  • Neglecting personal, professional, or family responsibilities
  • Continued use despite known adverse consequences
  • Spending significant time obtaining, using, or recovering from opioid use
  • Giving up previously important hobbies or activities

Physical Signs


  • Excessive drowsiness or sedation at inappropriate times
  • Slowed breathing or shallow respirations
  • Constricted (pinpoint) pupils
  • Physical withdrawal symptoms when not using
  • Unintentional weight loss or changes in appetite
  • Impaired coordination and slowed reaction time
  • Fluctuating energy levels

Psychological Effects

  • Marked mood fluctuations and emotional instability
  • Heightened anxiety, particularly between uses
  • Depressive episodes or persistent low mood
  • Intense cravings or preoccupation with obtaining opioids
  • Difficulty with cognitive functioning or concentration
  • Increased irritability or agitation
  • Feelings of hopelessness related to the pattern of use

Recognize these signs in yourself or someone you care about?

Opioid Withdrawal

When a person with physical opioid dependence reduces or stops use, withdrawal symptoms typically emerge. The onset, duration, and intensity of withdrawal vary depending on the specific opioid, frequency of use, and individual physiology. While opioid withdrawal is rarely life-threatening in otherwise healthy adults, it is profoundly uncomfortable and is a significant factor in relapse. Medical supervision greatly improves comfort and safety.

Early (6–24 hrs)

  • Anxiety and restlessness
  • Muscle aches
  • Increased tearing and runny nose
  • Yawning
  • Sweating

Peak (24–72 hrs)

  • Nausea and vomiting
  • Diarrhea
  • Severe muscle cramping
  • Insomnia
  • Goose bumps (piloerection)

Late (3–7+ days)

  • Persistent anxiety
  • Depression
  • Fatigue
  • Insomnia
  • Residual cravings

Post-Acute (weeks–months)

  • Mood dysregulation
  • Cognitive difficulties
  • Intermittent cravings
  • Sleep disturbances
  • Anxiety episodes

Medical Supervision Is Strongly Recommended

Attempting to manage opioid withdrawal without clinical support significantly increases discomfort and the risk of relapse. Medically supervised detoxification, available through inpatient rehabitation program, provides a safe and supportive environment for the withdrawal process under physician oversight.

Quick Clinical Facts

  • OUD requires ≥2 of 11 DSM-5 criteria in 12 months
  • Opioids bind mu-receptors, altering brain reward circuitry
  • Tolerance & dependence are neurobiological – not moral failings
  • Withdrawal is treatable with medical supervision
  • MAT is the gold-standard evidence-based treatment (SAMHSA/NIDA)
  • Overdose: call 911 immediately if suspected

Sources: NIDA, SAMHSA, DSM-5, CDC – all content medically reviewed.

Treatment Programs & Services

We offer a full continuum of care, from initial stabilization through long-term recovery support. Each program is guided by ASAM placement criteria and current clinical best practices.

24-hour supervised care in a medically managed residential environment for individuals with moderate to severe substance use disorders requiring intensive clinical support.

  • Appropriate for: Severe addiction, medical detox needs, unstable home environment
  • Duration: Typically 30–90 days
  • Components: Medical supervision, individual & group therapy, medication management

Flexible, therapy-based care that allows individuals to continue living at home while receiving structured clinical support and evidence-based treatment services.

  • Appropriate for: Mild to moderate symptoms, strong support system, step-down from inpatient
  • Duration: 3-12 months
  • Components: Individual therapy, group sessions, relapse prevention, family counseling

Integrated treatment for co-occurring substance use and mental health disorders. Research consistently demonstrates that simultaneous treatment of both conditions improves outcomes.

  • Appropriate for: Co-occurring depression, anxiety, PTSD, bipolar disorder with substance use
  • Duration: Varies by clinical assessment
  • Components: Psychiatric evaluation, integrated therapy, medication management

FDA-approved medications combined with counseling and behavioral therapies to provide a whole-patient approach to substance use disorder treatment.

  • Appropriate for: Opioid use disorder, alcohol use disorder, withdrawal management
  • Duration: Individualized; may be ongoing
  • Components: Buprenorphine, methadone, or naltrexone combined with behavioral counseling

Medical detox provides a safe, monitored environment to manage withdrawal symptoms as the body clears itself of substances. This process minimizes physical risks and ensures patient comfort before transitioning to ongoing therapy.

  • Appropriate for: Severe alcohol, opioid, or prescription drug dependence requiring medical intervention
  • Duration: 3 to 10 days, depending on the substance and severity
  • Components: 24/7 medical monitoring, medication-assisted treatment, withdrawal symptom management, transition planning

Insurance Coverage & Financial Options

The Mental Health Parity and Addiction Equity Act requires most insurance plans to cover substance use disorder treatment at parity with medical and surgical care. Beacon Addiction Care accepts most major insurance providers.

Our financial counselors work with each patient and family to maximize insurance benefits, explain out-of-pocket costs, and identify additional resources including state-funded programs and sliding-scale options.

Contact Us Today (302) 555-1234

Accepted Insurance Providers

  • Aetna
  • Cigna
  • Humana
  • Medicaid
  • TRICARE
  • BlueCross BlueShield
  • UnitedHealthcare
  • Kaiser Permanente
  • Medicare
  • Anthem

Don’t see your provider? Contact us – we work with most plans.

Frequently Asked Questions

Answers to common questions about our treatment programs, admissions process, and what to expect. For personalized guidance, contact our admissions team.

Opioid use disorder (OUD) is a recognized medical condition defined in the DSM-5 as a problematic pattern of opioid use that causes clinically significant impairment or distress. A diagnosis requires meeting at least two of eleven specified criteria within a 12-month period, which may include persistent cravings, inability to reduce or control use, tolerance, withdrawal, and continued use despite negative physical, psychological, or social consequences. OUD is a treatable, chronic condition – not a reflection of personal character or willpower.

Opioids carry a significant risk of physical and psychological dependence. They act on mu-opioid receptors in the brain’s reward and pain-regulation systems, producing powerful reinforcing effects. The National Institute on Drug Abuse (NIDA) notes that even short-term, clinically supervised opioid therapy can initiate neurobiological changes that increase dependence risk in some individuals. Risk is influenced by genetics, mental health history, method and duration of use, and the specific opioid involved. It is important to emphasize that dependence and addiction are medical phenomena, not moral failures.

Opioid withdrawal symptoms typically include muscle aches and cramping, nausea, vomiting, diarrhea, sweating, insomnia, anxiety, restlessness, and intense cravings. Early symptoms generally begin within 8–24 hours of the last use (varying by opioid type), peak within 36–72 hours, and may persist for several days to weeks. A post-acute withdrawal syndrome (PAWS) characterized by mood disturbances and intermittent cravings can continue for weeks to months. Medical supervision is strongly recommended to safely manage withdrawal symptoms and reduce the risk of relapse.

Warning signs of opioid overdose include extremely slow, shallow, or stopped breathing; unresponsiveness or inability to wake the person; blue or grayish discoloration of the lips, fingernails, or skin (cyanosis), gurgling or choking sounds; and constricted (pinpoint) pupils. If an overdose is suspected, call 911 immediately. Do not leave the person alone. Early emergency medical intervention is critical and can be life-saving.

Most insurance plans in the United States are required to cover substance use disorder treatment, including opioid addiction treatment. The Mental Health Parity and Addiction Equity Act (MHPAEA) requires that plans offering mental health and substance use benefits provide those benefits at parity with medical and surgical benefits. The Affordable Care Act (ACA) classifies substance use disorder services as an essential health benefit. Covered services may include detoxification, inpatient treatment, outpatient programs, MAT, and counseling. Specific coverage depends on your plan and network. We recommend verifying your benefits directly with your insurer.

Treatment duration varies considerably based on individual clinical needs. Short-term residential programs typically run 28–30 days, longer programs may last 60–90 days or more. Outpatient care can continue for many months to years. SAMHSA emphasizes that longer duration of treatment engagement is generally associated with improved outcomes. Recovery from OUD is often a long-term process that may include multiple levels of care over time, and this is both normal and expected.

Dual diagnosis treatment – also referred to as co-occurring disorder or integrated treatment – addresses both a substance use disorder (such as OUD) and a mental health condition (such as depression, anxiety, or PTSD) simultaneously within a single coordinated treatment plan. This integrated approach is recommended when both conditions are present, as each condition can influence the other. Treating only one while leaving the other unaddressed is associated with higher rates of relapse and poorer long-term outcomes.

Medication-assisted treatment (MAT) combines FDA-approved medications with counseling and behavioral therapies to treat opioid use disorder. These medications work by stabilizing brain chemistry, reducing cravings, and in some cases blocking the reinforcing effects of opioids. MAT is recognized by SAMHSA, NIDA, and the American Society of Addiction Medicine (ASAM) as the evidence-based gold standard for treating OUD. All medication decisions are made by a licensed prescribing clinician based on a thorough patient assessment. MAT is often used in combination with inpatient or outpatient treatment programs.

Reviewed by Dr. Emily Rodriguez

Specializes in trauma-informed care | CBT, DBT, EMDR
Last Updated: February 2026


Sources & Citations:

  • Centers for Disease Control and Prevention (CDC)
  • National Institute on Drug Abuse (NIDA)
  • National Institutes of Health (NIH)
  • Treatment Improvement Protocol (TIP 63), 2021
  • DSM-5-TR: Opioid Use Disorder Criteria
  • National Practice Guideline for OUD, 2023

Reviewed by Dr. Emily Rodriguez

Specializes in trauma-informed care | CBT, DBT, EMDR
Last Updated: February 2026


Sources & Citations:

  • Centers for Disease Control and Prevention (CDC)
  • National Institute on Drug Abuse (NIDA)
  • National Institutes of Health (NIH)
  • Treatment Improvement Protocol (TIP 63), 2021
  • DSM-5-TR: Opioid Use Disorder Criteria
  • National Practice Guideline for OUD, 2023

Medical Disclaimer: The information on this page is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition or treatment options.

Confidentiality Notice: Beacon Addiction Care is committed to protecting your privacy. All communications are handled in accordance with HIPAA (Health Insurance Portability and Accountability Act) regulations and 42 CFR Part 2 federal confidentiality requirements for substance use disorder treatment records.

Beacon Addiction Care does not guarantee specific treatment outcomes. Individual results vary based on the nature and severity of the substance use disorder, co-occurring conditions, and adherence to the treatment plan.

Professional Treatment Can Help Address Opioid Use Disorder

Speak confidentially with a licensed treatment specialist today. Our care coordinators can help you understand your options, verify your insurance coverage, and connect you with appropriate clinical resources – at no obligation.